$11.09
0.080.73%
Last update: Nov 10, 4:23 PM
Trulieve Cannabis Corp
TRLVNYSE
Trulieve Cannabis fell 4.3% from $11.50 to $11.01, behind the S&P 500's +3.4%. Its worst day was Sep 30 (−12.2%), and its low came Jul 29 at $8.06.
Jun 10, 2026 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Trulieve Cannabis shares fell 10.4%, while the S&P 500 rose 0.5%.
−10.4% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
Trulieve Cannabis closed at its lowest level of the year, 29.9% below where the year started.
−3.2% · S&P 500 −1.5%
EPS of $0.11 beat the $0.03 estimate on $271.0M revenue (est. $268.9M).
−2.8% · S&P 500 +0.6%
Trulieve Cannabis closed at its highest level of the year, 9.0% above where the year started.
+0.6% · S&P 500 −0.7%
EPS of $0.09 beat the $0.07 estimate on $230.0M revenue (est. $221.7M).
−6.0% · S&P 500 −4.4%
Where it ended: a close of $11.01 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 10, 2027 (EPS est. $0.11, revenue est. $233.7M).
Nothing in the past 12 months.
All TRLV dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TRLV and SPY from Benzinga historical bars. Not investment advice.
